Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Gains from Investment Securities (2017 - 2026)

Healthequity (HQY) has 11 years of Gains from Investment Securities data on record, last reported at $844000.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 91.84% year-over-year to $844000.0; the TTM value through Oct 2025 reached $9.6 million, down 72.08%, while the annual FY2025 figure was $26.1 million, 26.26% down from the prior year.
  • Gains from Investment Securities reached $844000.0 in Q4 2025 per HQY's latest filing, down from $6.6 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $13.2 million in Q3 2024 and bottomed at -$6.7 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $2.1 million, with a median of $277000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: crashed 761.94% in 2021, then soared 1057400.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$6.7 million in 2021, then surged by 95.15% to -$324000.0 in 2022, then skyrocketed by 97.84% to -$7000.0 in 2023, then surged by 147900.0% to $10.3 million in 2024, then crashed by 91.84% to $844000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $844000.0 in Q4 2025, $6.6 million in Q3 2025, and -$46000.0 in Q2 2025.